SARAH ROMERO: Open Payments
NPI 1265821326 · MORGAN CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 48 payments from 11 companies in 2025. Trend: 2023 $215 · 2024 $162 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $173 |
| AstraZeneca Pharmaceuticals LP | 10 | $155 |
| ABBVIE INC. | 5 | $87 |
| Novo Nordisk Inc | 4 | $61 |
| Lilly USA, LLC | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Corium, LLC | 2 | $18 |
Products named: ELIQUIS, TRINTELLIX, AIRSUPRA, UBRELVY, MOUNJARO, BREZTRI, Rybelsus, Ozempic.
Industry payments across LA — which companies pay providers there.
